Syngen Biotech Co.,Ltd.

8279

TW0008279001

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-06-25 pm EDT			5-day change	1st Jan Change
160 ^TWD	-0.62%		+1.91%	+5.26%

May. 13	Syngen Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 06	Syngen Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Syngen Biotech Co., Ltd. announced that it expects to receive TWD 21 million in funding

March 27, 2018

Syngen Biotech Co., Ltd. (GTSM:8279) announced a private placement of 2,100,000 common shares at a price of TWD 10 per share for gross proceeds of TWD 21,000,000 on March 28, 2018.

Latest news about Syngen Biotech Co.,Ltd.

Syngen Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Syngen Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Syngen Biotech Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-30	CI
Syngen Biotech Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Syngen Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Syngen Biotech Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-26	CI
Syngen Biotech Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-27	CI
Syngen Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Syngen Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-08	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-26	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-28	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-03	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-09	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-29	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-04	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-05	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-25	CI
ADAMA : ChemChina, Sinochem merge agricultural assets - Syngenta	20-01-05	RE
Syngen Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-06	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-07	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-08	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-24	CI
Syngen Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2018	18-11-07	CI
Syngen Biotech Co., Ltd. announced that it expects to receive TWD 21 million in funding	18-03-27	CI

Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

160 TWD

Average target price

170 TWD

Spread / Average Target

+6.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SYNGEN BIOTECH CO.,LTD.	+5.26%	133M
ELI LILLY AND COMPANY	+54.61%	811B
NOVO NORDISK A/S	+43.59%	640B
JOHNSON & JOHNSON	-6.33%	353B
MERCK & CO., INC.	+20.62%	333B
ABBVIE INC.	+10.44%	302B
ASTRAZENECA PLC	+17.51%	246B
ROCHE HOLDING AG	+2.33%	225B
NOVARTIS AG	+12.47%	218B
AMGEN INC.	+8.61%	168B

Other Pharmaceuticals